Charles River Laboratories (CRL) Tops Q2 EPS by 40c; lowers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 351.87 +13.33 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $338.54 | 52 Week High | $89.18 | |||
| Open | $339.88 | 52 Week Low | $65.70 | |||
| Day High | $356.35 | P/E | 163.66 | |||
| Day Low | $338.55 | EPS | $2.15 | |||
| Volume | 1,595,811 | |||||
